Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment
Authors:
Open Access
- 14 September 2016
- journal article
- research article
- Published by S. Karger AG in Liver Cancer
- Vol. 5 (4) , 257-268
Abstract
Objectives: This study aimed to build a prediction score of prognosis for patients with advanced hepatocellular carcinoma (HCC) after sorafenib treatment. Methods: A total of 165 patients with advanced HCC who were treated with sorafenib were analyzed. Readily available baseline factors were used to establish a scoring system for the prediction of survival. Results: The median survival time (MST) was 14.2 months. The independent prognostic factors were C-reactive protein (CRP) 3.5 g/dL (HR =0.55), alpha-fetoprotein Conclusions: A novel prognostic scoring system, which includes the CRP level, has the ability to stratify the prognosis of patients with advanced stage HCC after treatment with sorafenib.Keywords
This publication has 43 references indexed in Scilit:
- Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular CarcinomasJournal of Pathology and Translational Medicine, 2015
- Usefulness of a new inflammation-based scoring system for prognostication of patients with hepatocellular carcinoma after hepatectomyThe American Journal of Surgery, 2015
- Hepatocellular carcinoma: clinical frontiers and perspectivesGut, 2014
- Sorafenib: from literature to clinical practiceAnnals of Oncology, 2013
- Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinomaLiver Transplantation, 2012
- Hepatocellular carcinomaThe Lancet, 2012
- Analysis of Factors Affecting Recurrence of Hepatocellular Carcinoma After Liver Transplantation With a Special Focus on Inflammation MarkersTransplantation, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- New Strategies in Hepatocellular Carcinoma: Genomic Prognostic MarkersClinical Cancer Research, 2010
- Serum C‐reactive protein levels predict survival in hepatocellular carcinomaLiver International, 2007